Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: A multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial
- Uwe Platzbecker
- , Raymond S.M. Wong
- , Amit Verma
- , Camille Abboud
- , Sergio Araujo
- , Tzeon Jye Chiou
- , John Feigert
- , Su Peng Yeh
- , Katharina Götze
- , Norbert Claude Gorin
- , Peter Greenberg
- , Suman Kambhampati
- , Yoo Jin Kim
- , Je Hwan Lee
- , Roger Lyons
- , Marco Ruggeri
- , Valeria Santini
- , Gregory Cheng
- , Jun Ho Jang
- , Chien Yuan Chen
- Universitätsklinikum Carl Gustav Carus Dresden
- Prince of Wales Hospital Hong Kong
- Albert Einstein College of Medicine of Yeshiva University
- Washington University School of Medicine in St. Louis
- Universidade Federal de Minas Gerais
- National Yang-Ming University Taiwan
- Georgetown University School of Medicine
- China Medical University Hospital
- UPMC Univ Paris
- Stanford Cancer Institute
- University of Kansas Medical School
- The Catholic University of Korea Seoul St. Mary's Hospital
- Asan Medical Center
- Comprehensive Cancer Centers of Nevada
- San Bortolo Hospital
- Unit of Gastroenterology SOD2
- Macau University of Science and Technology
- Samsung Medical Center, Sungkyunkwan University
- National Taiwan University Hospital
- GlaxoSmithKline, USA
- University of Rochester Medical Center
- Cellzome GmbH
- Marienkrankenhaus Düsseldorf-Kaiserswerth
Research output: Contribution to journal › Article › peer-review
69
Scopus
citations